The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae
- 1 November 2000
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 38 (3) , 151-157
- https://doi.org/10.1016/s0732-8893(00)00185-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- New Antibiotics in Pulmonary and Critical Care Medicine: Focus on Advanced Generation Quinolones and CephalosporinsSeminars in Respiratory and Critical Care Medicine, 2000
- Pharmacodynamic Comparisons of Levofloxacin, Ciprofloxacin, and Ampicillin against Streptococcus pneumoniae in an In Vitro Model of InfectionAntimicrobial Agents and Chemotherapy, 1999
- Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniaeJournal of Antimicrobial Chemotherapy, 1999
- Levofloxacin Population Pharmacokinetics and Creation of a Demographic Model for Prediction of Individual Drug Clearance in Patients with Serious Community-Acquired InfectionAntimicrobial Agents and Chemotherapy, 1998
- Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during TherapyAntimicrobial Agents and Chemotherapy, 1998
- Pharmacodynamics of LevofloxacinJAMA, 1998
- Principles of Good Practice for the Use of Monte Carlo Techniques in Human Health and Ecological Risk AssessmentsRisk Analysis, 1994
- Pharmacodynamics of intravenous ciprofloxacin in seriously ill patientsAntimicrobial Agents and Chemotherapy, 1993
- Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsisAntimicrobial Agents and Chemotherapy, 1993
- Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolonesThe American Journal of Medicine, 1991